Pfizer CEO Urges US-China Pharma Collaboration Amid Rapid Chinese Innovation
TL;DR Summary
CEOs of Wells Fargo and Pfizer warn that the U.S. risks losing its global edge to China without increased innovation, emphasizing AI's potential to boost productivity and revolutionize medicine, while highlighting the need for regulatory reforms and strategic focus on innovation to maintain competitiveness.
- CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation CNBC
- Pfizer CEO says US pharma industry needs to collaborate with China Reuters
- Pfizer CEO touts China's 'dramatic speed' in biopharma, calls for U.S. collaboration Seeking Alpha
- Pfizer (PFE) CEO Highlights China's Rapid Drug Development GuruFocus
- Pfizer CEO Urges US-China Collaboration In Pharma; Stock Drops For 7th Day As Traders Hold For Dividend Payout Stocktwits
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
91%
508 → 44 words
Want the full story? Read the original article
Read on CNBC